• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 119.00(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medico Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71781.0
  • ISIN : INE630Y01024
48.88 2 (4.20%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    46.47

  • Today’s High

    50.70

  • Open

    47.00

  • Perv Close

    46.91

  • 52W Low

    35.67

  • 52W High

    79.83

Key Indicators

  • P/E(TTM)

    40.09

  • Mar.Cap (₹Cr.)

    405.63

  • Div & Yield %

    0.00

  • Book Value(₹)

    7.53

  • Debt-Equity Ratio

    4.20

  • AGM Date

    17-Jun-2025

  • EPS

    1.22

  • P/E Ratio

    40.09

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    405.63

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.60

  • BV (₹)

    7.50

  • Sales( ₹ in Cr.)

    150.94

  • NP (in Cr.)

    10.09

  • NP Var(%)

    22.0

  • Div%

    0.0

  • CPS (₹)

    1.60

  • EPS (₹)

    1.20

  • Traded Value (₹ in Lakhs)

    405.87

  • 52 Week High

    79.83

  • 52 Week Low

    35.67

  • Price BSE

    49.0

  • Price NSE

    49.00

  • Market Capital( in Cr.)

    405.87

  • P/C Ratio

    31.00

  • P/E Ratio

    40.30

  • Price Vs.BV

    1.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 144.92 140.44 121.02 122.39 88.64 97.69
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 144.92 140.44 121.02 122.39 88.64 97.69
Other Income 2.13 3.95 2.03 1.03 2.10 1.90
Stock Adjustments -2.04 1.18 0.26 -1.54 3.63 0.82
Total Income 145.01 145.57 123.31 121.88 94.37 100.41
EXPENDITURE :            
Raw Materials 107.87 106.05 87.55 90.69 70.81 80.34
Power and Fuel Cost 2.55 2.47 2.29 1.91 1.83 1.73
Employee Cost 5.92 5.68 5.41 4.50 3.83 3.32
Other Manufacturing Expenses 6.25 5.48 6.44 5.25 4.56 3.55
Selling and Administration Expenses 6.42 11.92 11.20 10.60 7.72 6.10
Miscellaneous Expenses 0.97 0.40 1.05 2.66 0.68 0.71
Employee Benefit Expenses 5.92 5.68 5.41 4.50 3.83 3.32
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 129.97 132.00 113.95 115.61 89.42 95.75
Operating Profit 15.03 13.57 9.36 6.27 4.94 4.67
Interest 0.82 0.75 0.66 0.92 1.06 0.98
Gross Profit 14.21 12.82 8.70 5.35 3.88 3.69
Depreciation 2.88 2.72 2.22 1.65 1.66 1.51
Profit Before Tax 11.33 10.10 6.48 3.70 2.22 2.18
Current Tax 3.17 2.50 1.79 1.06 0.57 0.55
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.12 0.36 -0.12 0.05 0.01 0.06
Reported Net Profit 8.29 7.24 4.81 2.59 1.63 1.57
Extraordinary Items 0.00 0.00 -0.03 0.00 0.00 0.00
Adjusted Net Profit 8.29 7.24 4.84 2.59 1.63 1.57
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 23.92 16.67 11.86 9.91 8.28 6.71
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 32.21 23.92 16.67 12.50 9.91 8.28
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.00 0.87 2.90 6.24 3.93 3.78
Earnings Per Share(Adj)-Unit Curr 1.00 0.87 0.58 0.31 0.20 0.19
Book Value 6.31 5.28 22.04 78.22 71.98 68.05
Book Value(Adj)-Unit Curr 6.31 5.28 4.41 3.91 3.60 3.40

Shareholding Pattern

  • Promoter Group

    63.79%

  • Public Share Holding

    36.21%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 52,937,145 63.79 52,937,145 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 52,937,145 63.79 52,937,145 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 97,122 0.12 97,122 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,279 0.01 11,279 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 108,401 0.13 108,401 7
2] Non Institution
Bodies Corporate 3,832,434 4.62 3,832,034 65
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 304,948 0.37 304,948 112
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 6,664,532 8.03 6,663,732 187
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,146,229 8.61 7,146,229 31
Individuals holding nominal share capital up to Rs. 1 lakh 11,221,310 13.52 11,219,710 15,012
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 29,938,454 36.08 29,935,654 15,411
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 82,984,000 100.00 82,981,200 15,424

Company Background

Medico Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Medico Remedies Ltd
  • BSE Code : 71781.0
  • ISIN : INE630Y01024

  • Incorporation Year

    1994

  • Registered Office

    1105/1106 11-Flr Hubtown Solar
    N S Phadke Marg Andheri East, Mumbai,
    Maharashtra-400069

  • Telephone

    91-22-2670 1055/66

  • FAX

  • Chairman

    Haresh Mehta

  • Managing Director

    Harshit Mehta

  • Company Secretary

  • Auditor

    V J Shah & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Medico Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medico Remedies 48.91 147.05 144.92 40.09 21.24
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92